Related Experiment Video
Updated: Jun 29, 2026

09:49
Isolation and Cannulation of Cerebral Parenchymal Arterioles
Published on: May 23, 2016
A Pilot Study Evaluating Cerebral Vasculitis in Kawasaki's Disease.
Jung Sook Yeom1,2, Young Hye Cho1, Chung Mo Koo3
1Department of Pediatrics, Gyeongsang National University of Hospital, Jinju, Republic of Korea.
Neuropediatrics
|June 19, 2018
Summary
Cerebral vasculitis in Kawasaki
Area of Science:
- Neurology
- Pediatrics
- Immunology
Background:
- Kawasaki disease (KD) can lead to severe neurological complications, potentially due to cerebral vasculitis.
- Investigating intracranial inflammation is crucial for understanding KD's neurological impact.
- Cytokines like IL-6, TNF-α, and PTX3 are potential markers of inflammation.
Purpose of the Study:
- To evaluate the intracranial inflammatory response in acute-stage Kawasaki disease.
- To measure levels of IL-6, TNF-α, and PTX3 in cerebrospinal fluid of KD patients.
- To compare these levels with febrile control groups.
Main Methods:
- Cerebrospinal fluid samples were collected from KD patients (n=7) and control groups (bacterial meningitis, enteroviral meningitis, non-specific viral illness).
- Levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and pentraxin-3 (PTX3) were measured.
- Statistical comparisons were made between KD patients and age/sex-matched controls.
Main Results:
- PTX3 and TNF-α were rarely detected in KD patients' cerebrospinal fluid.
- IL-6 levels in KD patients were comparable to those with non-specific viral illnesses.
- No significant difference in measured inflammatory markers was observed between KD and control groups.
Conclusions:
- Intracranial inflammation, including vasculitis, appears insignificant in the studied KD patients.
- The studied inflammatory mediators are not established biomarkers for cerebral vasculitis in KD.
- Further research is needed in KD patients with neurological symptoms and confirmed cerebral vessel involvement.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...

